Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
|
|
|
9.
|
124 I-Nal PET/CT Based 3-D radiobiological dosimetry (3D-RD) for 131I-Nal therapy of metastatic well-differentiated thyroid cancer. MedStar authors:
- Atkins, Frank
- Khorjekar, Gauri
- Orquiza, Michael D
- Van Nostrand, Douglas
Year: 2013
Department: - Department of Medicine/Nuclear Medicine
All authors: - Senthamizhchelvan S, Hobbs R, Atkins F, Khorjekar G, Orquiza M, Van Nostrand D, Sgouros G
|
|
|
10.
|
|
|
|
11.
|
|
|
|
12.
|
|
|
|
13.
|
|
|
|
14.
|
|
|
|
15.
|
The public sites and frequency of detection of patients treated with 131I and the security management of those patients: the final report of a national survey MedStar authors:
- Bethancourt, E
- Bikas, A
- Burman, Kenneth D
- Orquiza, Michael H
- Van Nostrand, Douglas
- Wartofsky, Leonard
Year: 2015
Department:
- Medicine/Endocrinology
- Medicine/Nuclear Medicine
All authors: - Bethancourt E, Van Nostrand D, Orquiza M, Bloom G, Bikas A, Burman k, Wartofsky l
|
|
|
16.
|
The frequency and content of documents issued for patients' 131I therapies for security agents: the final report of a national survey MedStar authors:
- Bethancourt, E
- Bikas, A
- Burman, Kenneth D
- Orquiza, Michael H
- Van Nostrand, Douglas
- Wartofsky, Leonard
Year: 2015
Department:
- Medicine/Endocrinology
- Medicine/Nuclear Medicine
All authors: - Bethancourt E, Van Nostrand D, Orquiza M, Bloom G, Bikas A, Burman k, Wartofsky l
|
|
|
17.
|
Characterization of sialoadenitis after administration of continous sialogogues during the day and night After 131 I therapy. MedStar authors:
- Acio, Elmo
- Burman, Kenneth D
- Garcia, Carlos
- Khorjekar, Gauri
- Kulkarni, Kanchan
- Orquiza, Michael D
- Schneider, Mark
- Wartofsky, Leonard
Year: 2013
Department:
- Department of Medicine/Endocrinology
- Department of Medicine/Nuclear Medicine
All authors: - Orquiza M, Khorjekar G, Schneider M, Kulkarni K, Garcia C, Acio E, Burman K, Wartofsky L
|
|
|
18.
|
|
|
|
19.
|
Survival rate in differentiated thyroid cancer patients with bone metastases. MedStar authors:
- Atkins, Francis
- Burman, Kenneth D
- Khorjekar, Gauri R
- Kulkarni, Kanchan
- Moreau, Shari
- Orquiza, Michael H
- Van Nostrand, Douglas
- Wartofsky, Leonard
Year: 2014
Department:
- Medicine/Endocrinology
- Medicine/General Internal Medicine
- Medicine/Nuclear Medicine
All authors: - Orquiza M, Van Nostrand D, Khorjekar G, Moreau S, Atkins F, Kulkarni K, Burman KD, Wartofsky L
|
|
|
20.
|
Altered taste after 131I therapy: the frequency, time of onset, severity, and duration MedStar authors:
- Acio, Elmo
- Burman, Kenneth D
- Garcia, Carlos
- Khorjekar, Gauri R
- Kulkarni, Kanchan
- Orquiza, Michael H
- Schneider, M
- Van Nostrand, Douglas
- Wartofsky, Leonard
Year: 2014
Department:
- Medicine/Endocrinology
- Medicine/General Internal Medicine
- Medicine/Nuclear Medicine
All authors: - Orquiza M, Khorjekar G, Schneider M, Kulkarni K, Garcia C, Acio E, Burman K, Wartofsky L,Van Nostrand D
|
|
|
21.
|
Epiphora and xerophthalmia after 131I therapy: the frequency, time of onset, severity, and duration. MedStar authors:
- Acio, Elmo
- Burman, Kenneth D
- Garcia, Carlos
- Khorjekar, Gauri R
- Kulkarni, Kanchan
- Orquiza, Michael H
- Schneider, M
- Van Nostrand, Douglas
- Wartofsky, Leonard
Year: 2014
Department:
- Medicine/Endocrinology
- Medicine/General Internal Medicine
- Medicine/Nuclear Medicine
All authors: - Orquiza M, Khorjekar G, Schneider M, Kulkarni K, Garcia C, Acio E, Burman K, Wartofsky L, Van Nostrand D
|
